GC
OCDX

Guggenheim Capital’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Guggenheim Capital’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-86,513
Closed -$1.61M – 2178
2022
Q1 		$1.61M Buy
+86,513
New +$1.56M 0.01% 1126

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Guggenheim Capital's OCDX Position: Q2 2022 in Review

Guggenheim Capital sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 86,513 shares — an estimated $1.61M sold.

Guggenheim Capital first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $1.61M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Guggenheim Capital reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Guggenheim Capital sold 86,513 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.61M.
  • Guggenheim Capital first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Guggenheim Capital's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.61M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.